the lipoprotein lowering effect of gemfibrozil , 400 mg twice daily , was studied for 24 weeks in 26 subjects with primary hyperlipoproteinaemia ( type iia , 5 ; iib , 3 ; iii , 3 ; and iv , 15 ) .
C0017245
gemfibrozil
C0020476
hyperlipoproteinaemia